Galectin Therapeutics, Inc. Gains 25.58%
Wed, Jun 01, 2022 at 05:30 PM
Galectin Therapeutics, Inc. (GALT:NASDAQ) shot up at $1.62, representing a gain of 25.6%. On Tue, May 31, 2022, GALT:NASDAQ hit a New 2-Week Intraday High of $1.35. The stock got featured on our News Catalysts scanner on Mon, May 23, 2022 at 09:43 AM in the 'MISCELLANEOUS' category. From Tue, May 17, 2022, the stock recorded 55.56% Up Days and 50.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Galectin Therapeutics, Inc. (GALT:NASDAQ)
Galectin Therapeutics Inc is a clinical stage biopharmaceutical company. The Company is engaged in drug research and development to create new therapies for fibrotic disease and cancer.
Top 10 Gainers:
- Missfresh Limited (MF:NASDAQ), 51.05%
- Spark Networks SE (LOV:NASDAQ), 38.39%
- Energy Focus, Inc. (EFOI:NASDAQ), 37.42%
- View Inc. (VIEW:NASDAQ), 33.07%
- 180 Life Sciences Corp. (ATNF:NASDAQ), 31.48%
- vTv Therapeutics Inc. (VTVT:NASDAQ), 30.62%
- Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ), 29.1%
- Galectin Therapeutics, Inc. (GALT:NASDAQ), 25.58%
- Hillstream BioPharma Inc. (HILS:NASDAQ), 21.23%
- Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ), 19.76%